NIHR Biomedical Research Centre: Oxford

Enabling translational research through partnership

NIHR 20th Anniversary NIHR website
NIHR Biomedical Research Centre: Oxford
  • Home
  • About
    • About us
    • Impact
    • Our next BRC
    • Steering Committee
    • Promoting equality, diversity and inclusion in research
    • Current Vacancies
    • Stay in Touch
    • Contact Us
  • Research
    • Research Overview
      • NIHR Clinical Research Facility
      • Ethics in the NIHR BRC: Oxford
      • Health Economics
      • Medical Statistics
    • Cancer
    • Cardiovascular Medicine
    • Digital Health from Hospital to Home
    • Gene and Cell Therapy
    • Genomic Medicine
    • Imaging
    • Inflammation across Tissues
    • Life-saving Vaccines
    • Metabolic Experimental Medicine
    • Modernising Medical Microbiology and Big Infection Diagnostics
      • Theme overview
      • Infections in Oxfordshire Database (IORD)
    • Musculoskeletal
    • Preventive Neurology
    • Respiratory Medicine
    • Surgical Innovation, Technology and Evaluation
    • Translational Data Science
  • Patient & Public Involvement
    • For patients and the public
    • For researchers
    • More information
  • Training
  • Industry & Partnerships
  • News
  • Events
  • Videos

News

An aspirin a day helps to keep cancer at bay

7 December 2010 · Listed under Cancer

Taking a low-dose aspirin every day will reduce your chances of dying from cancer, scientists say today, confirming the over-the-counter pill as the most extraordinary drug yet discovered.

Daily aspirin has already been shown to cut the chances of heart attacks and stroke in people who are at risk. The study published today in the Lancet medical journal reveals that it also has a powerful preventive action against a range of cancers – and possibly more of them than there is currently enough evidence to prove.

While the doctors who carried out the study say it is not for them to make recommendations, the lead author, 46-year-old Prof Peter Rothwell from Oxford University, says he has been taking aspirin for the last two years. The beneficial dose is 75mg – a quarter of a standard tablet, which is 300mg. Some pharmacies sell low-dose tablets, but at a higher price.

← Aspirin ‘can significantly reduce’ bowel cancer risk
ARCII-study in Oxford – the human face of medical breakthrough →

Other news

News Categories

News by Month

See all news
You are here: Home > Cancer > An aspirin a day helps to keep cancer at bay

Subscribe to the BRC Oxford Newsletter

Keep informed about the work of the BRC Oxford by subscribing to our Mailchimp e-newsletter. It is produced several times a year and delivers news and information about upcoming events straight to your inbox.

Subscribe Now

Feedback

We’d love to hear your feedback. Please contact us at obrcenquiries@ouh.nhs.uk

BRC Oxford on Social Media

  • Bluesky
  • Facebook
  • LinkedIn
  • YouTube
  • Data Control and Privacy
  • Accessibility
  • Our Partners
  • Disclaimer
  • Contact

Copyright © 2026 NIHR Biomedical Research Centre: Oxford